Patients with chronic pancreatitis have a much higher annual risk to develop pancreatic cancer and need to be watched closely
Sharon Fruh: Served on advisory board for Novo Nordisk
GLP1s may be revealing just how dynamic and deeply personal that sensory landscape really is
doi: 10.1016/j.clinre.2016.11.009 Summary Keywords glucagon-like peptide-1 receptor agonists, metabolic disease, metabolic dysfunction-associated steatotic liver disease, public health, umbrella review Citation Wu H, Zhang Z-H, Ye T, Chen J-N, Tung T-H and Zhu J-S (2026) Efficacy and safety of GLP-1 receptor agonists in patients with metabolic-associated fatty liver diseases: an umbrella review
Learn more about transitioning to adult primary care or find a provider near you
It also slows gastrointestinal motility, meaning that gastric (stomach) emptying is slowed down, and food will move through the GI tract more slowly